Great Diamond Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.65M Buy
19,577
+258
+1% +$53.6K 0.8% 31
2026
Q1
$4.08M Buy
19,319
+1,228
+7% +$264K 0.79% 32
2025
Q4
$3.72M Buy
18,091
+489
+3% +$92K 0.72% 32
2025
Q3
$2.76M Buy
17,602
+766
+5% +$118K 0.54% 49
2025
Q2
$2.83M Buy
16,836
+1,494
+10% +$222K 0.6% 43
2025
Q1
$2.11M Sell
15,342
-697
-4% -$88.8K 0.58% 51
2024
Q4
$1.9M Sell
16,039
-4
-0% -$467 0.49% 62
2024
Q3
$1.77M Sell
16,043
-2,020
-11% -$211K 0.45% 63
2024
Q2
$1.78M Buy
18,063
+296
+2% +$30.2K 0.42% 66
2024
Q1
$1.99M Buy
17,767
+12,263
+223% +$1.32M 0.46% 61
2023
Q4
$555K Buy
5,504
+235
+4% +$23.3K 0.14% 126
2023
Q3
$457K Buy
5,269
+55
+1% +$4.97K 0.12% 134
2023
Q2
$493K Buy
+5,214
New +$440K 0.13% 130

Other funds holding CAH

Great Diamond Partners's CAH Position: Q2 2026 in Review

Great Diamond Partners increased its Cardinal Health (CAH) stake by 1.3% in Q2 2026, buying an estimated $53.6K and bringing the position to 19,577 shares worth $4.65M. The position accounts for 0.8% of the portfolio, ranked #31.

Great Diamond Partners first reported a position in CAH in Q2 2023 and has held it in 13 quarters since. 617 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Great Diamond Partners held 19,577 shares of Cardinal Health worth $4.65M as of Q2 2026.
  • Great Diamond Partners bought 258 Cardinal Health shares in Q2 2026, an estimated $53.6K.
  • Cardinal Health made up 0.8% of Great Diamond Partners's portfolio in Q2 2026, its #31 holding.
  • Great Diamond Partners first reported a position in Cardinal Health in Q2 2023 and has held it in 13 quarters since.
  • 617 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Great Diamond Partners's 13F filing for Q2 2026, filed 17 Jul 2026.